LEXINGTON, Mass.--(BUSINESS WIRE)--
Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will
report its third quarter 2016 financial results on Tuesday, November 8,
2016, before the U.S. financial markets open. The Company will host a
conference call and webcast at 8:30 a.m. EST to discuss third quarter
financial results and provide a business update. Individuals interested
in participating in the call should dial (855) 354-1855 (U.S. and
Canada) or (484) 365-2865 (International).
In addition, the Company today announced that it will present a
corporate overview at the following upcoming investor conferences:
The Stifel 2016 Healthcare Conference on November 15, 2016, at 2:15
p.m. EST in New York, NY; and
Jefferies 2016 London Healthcare Conference on November 16, 2016, at
3:20 p.m. GMT in London.
A live webcast of these presentations including the third quarter
financial results may be accessed in the Investors
section of the Company's website at www.concertpharma.com.
Please log on to the Concert website approximately 15 minutes prior to
the scheduled webcast to ensure adequate time for any software downloads
that may be required. A replay of the third quarter financial results
webcast will be available on Concert's website for three months. A
replay of the investor conference webcasts will be available on
Concert's website for two weeks following each presentation.
Pharmaceuticals is a clinical stage biopharmaceutical company
focused on applying its DCE
Platform® (deuterated chemical entity platform) to create novel
medicines designed to address unmet patient needs. The Company's
approach starts with approved drugs in which deuterium substitution has
the potential to enhance clinical safety, tolerability or efficacy.
Concert has a broad
pipeline of innovative medicines targeting pulmonary diseases,
including cystic fibrosis, central nervous systems (CNS) disorders, as
well as autoimmune and inflammatory diseases. For more information
please visit www.concertpharma.com.
Concert Pharmaceuticals Inc., the CoNCERT Pharmaceuticals Inc. logo and
DCE Platform are registered trademarks of Concert Pharmaceuticals, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161101005270/en/
Concert Pharmaceuticals, Inc.
Justine Koenigsberg, 781-674-5284
Source: Concert Pharmaceuticals, Inc.
News Provided by Acquire Media